NGM Ngm Biopharmaceuticals Inc

Price (delayed)

$20.37

Market cap

$1.57B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.58

Enterprise value

$1.42B

Highlights
NGM's equity is up by 43% since the previous quarter and by 25% year-on-year
Ngm Biopharmaceuticals's quick ratio has increased by 47% QoQ but it has decreased by 12% YoY
The net income has plunged by 107% YoY and by 8% from the previous quarter
The company's EPS has shrunk by 90% YoY and by 5% QoQ

Key stats

What are the main financial stats of NGM
Market
Shares outstanding
77.02M
Market cap
$1.57B
Enterprise value
$1.42B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.91
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$110.92M
EBITDA
-$104.54M
Free cash flow
-$88.09M
Per share
EPS
-$1.58
Free cash flow per share
-$1.16
Book value per share
$5.21
Revenue per share
$0
TBVPS
$5.86
Balance sheet
Total assets
$445.54M
Total liabilities
$45.96M
Debt
$0
Equity
$399.58M
Working capital
$385.54M
Liquidity
Debt to equity
0
Current ratio
10.56
Quick ratio
10.28
Net debt/EBITDA
1.43
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-30.6%
Return on equity
-35.3%
Return on invested capital
-90.8%
Return on capital employed
-27.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NGM stock price

How has the Ngm Biopharmaceuticals stock price performed over time
Intraday
2.46%
1 week
11.31%
1 month
-28.3%
1 year
-9.55%
YTD
-32.77%
QTD
-29.93%

Financial performance

How have Ngm Biopharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$195.59M
Net income
-$110.92M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 107% YoY and by 8% from the previous quarter
The operating income has contracted by 20% YoY and by 2.3% from the previous quarter

Growth

What is Ngm Biopharmaceuticals's growth rate over time

Valuation

What is Ngm Biopharmaceuticals stock price valuation
P/E
N/A
P/B
3.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 90% YoY and by 5% QoQ
NGM's equity is up by 43% since the previous quarter and by 25% year-on-year
The stock's price to book (P/B) is 28% less than its last 4 quarters average of 5.4

Efficiency

How efficient is Ngm Biopharmaceuticals business performance
NGM's return on assets has dropped by 119% year-on-year
The return on equity has dropped by 119% year-on-year
The company's return on invested capital rose by 32% QoQ but it fell by 28% YoY

Dividends

What is NGM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NGM.

Financial health

How did Ngm Biopharmaceuticals financials performed over time
Ngm Biopharmaceuticals's quick ratio has increased by 47% QoQ but it has decreased by 12% YoY
The current ratio has grown by 46% from the previous quarter but it has contracted by 11% YoY
Ngm Biopharmaceuticals's debt is 100% lower than its equity
NGM's equity is up by 43% since the previous quarter and by 25% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.